John Militello reports a stock award at IRulya Therapeutics
By AlphaYouPublished Form 4
Militello John
Reporting filer
John Militello reports a stock award, not an open-market purchase or sale, in IRulya Therapeutics Inc.. Form 4 filed Nov 12, 2026 lists 1 entry.
- Disclosed
- Nov 12, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stotck | Militello John | 2026-11-09 | A | Grant or award | 80000 | 0 | 80,000 | 3 days | Filed terms
|
Common Stotck
- Owner
- Militello John
- Date
- 2026-11-09
- Code
- A
- Action
- Grant or award
- Quantity
- 80000
- Price
- 0
- Following holdings
- 80,000
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stotck
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 80000
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 80000
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Militello John: Chief Financial Officer.
- F1: Represents restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's 2026 Equity Incentive Plan (the "2026 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock on the vesting date of the RSUs. 25% of the RSUs vest on the last day of the calendar quarter in which the first anniversary of the Vesting Commencement Date of July 8, 2026 occurs and an additional 6.25% of the RSUs vest at the end of each subsequent calendar quarter thereafter, subject to the Reporting Person's Continued Service (as defined in the 2026 Plan) with the Issuer as of each such vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.